Hudson Capital Management’s Colgate-Palmolive CL Stock Holding History

Hudson Capital Management’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-48,159	Closed	-$3.84M	–	65
2023 Q4	$3.84M	Buy	48,159 +1,735	+4%	+$130K	1.39%	33
2023 Q3	$3.3M	Buy	46,424 +4,127	+10%	+$309K	1.32%	36
2023 Q2	$3.26M	Buy	42,297 +1,678	+4%	+$130K	1.25%	36
2023 Q1	$3.05M	Buy	40,619 +2,607	+7%	+$194K	1.21%	36
2022 Q4	$2.99M	Buy	38,012 +4,776	+14%	+$358K	1.19%	33
2022 Q3	$2.33M	Buy	33,236 +2,046	+7%	+$160K	1.16%	31
2022 Q2	$2.5M	Buy	31,190 +3,312	+12%	+$259K	1.19%	20
2022 Q1	$2.11M	Buy	27,878 +1,250	+5%	+$99K	0.84%	37
2021 Q4	$2.27M	Buy	26,628 +441	+2%	+$34.4K	0.82%	38
2021 Q3	$1.98M	Buy	26,187 +1,374	+6%	+$109K	0.79%	36
2021 Q2	$2.02M	Buy	24,813 +1,403	+6%	+$115K	0.84%	40
2021 Q1	$1.84M	Buy	23,410 +3,219	+16%	+$252K	0.79%	38
2020 Q4	$1.73M	Buy	20,191 +5,391	+36%	+$446K	0.77%	41
2020 Q3	$1.14M	Buy	+14,800	New	+$1.13M	0.56%	43

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Hudson Capital Management's CL Position: Q1 2024 in Review

Hudson Capital Management sold out of Colgate-Palmolive (CL) in Q1 2024, closing a stake of 48,159 shares — an estimated $3.84M sold.

Hudson Capital Management first reported a position in CL in Q3 2020 and held it in 14 quarters. The position peaked at $3.84M in Q4 2023. 1,765 funds tracked by Wall St. Rank hold CL as of Q1 2024.

Hudson Capital Management reported no remaining Colgate-Palmolive position as of Q1 2024 after selling out during the quarter.
Hudson Capital Management sold 48,159 Colgate-Palmolive shares in Q1 2024, an estimated $3.84M.
Hudson Capital Management first reported a position in Colgate-Palmolive in Q3 2020 and held it in 14 quarters.
Hudson Capital Management's Colgate-Palmolive position peaked at $3.84M in Q4 2023.
1,765 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2024.

Based on Hudson Capital Management's 13F filing for Q1 2024, filed 19 Apr 2024.